These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19681677)

  • 1. Proteomics and liver fibrosis: identifying markers of fibrogenesis.
    Mas VR; Fisher RA; Archer KJ; Maluf DG
    Expert Rev Proteomics; 2009 Aug; 6(4):421-31. PubMed ID: 19681677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.
    Gressner OA; Weiskirchen R; Gressner AM
    Clin Chim Acta; 2007 Jun; 381(2):107-13. PubMed ID: 17399697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fibrosis: from the bench to clinical targets.
    Pinzani M; Rombouts K
    Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis.
    Zehra M; Curry JC; Pillai SS; Lakhani HV; Edwards CE; Sodhi K
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the clinical use of collagen as biomarker of liver fibrosis.
    Meurer SK; Karsdal MA; Weiskirchen R
    Expert Rev Mol Diagn; 2020 Sep; 20(9):947-969. PubMed ID: 32865433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamically remodeled hepatic extracellular matrix predicts prognosis of early-stage cirrhosis.
    Wu Y; Cao Y; Xu K; Zhu Y; Qiao Y; Wu Y; Chen J; Li C; Zeng R; Ge G
    Cell Death Dis; 2021 Feb; 12(2):163. PubMed ID: 33558482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.
    Gressner AM; Gao CF; Gressner OA
    World J Gastroenterol; 2009 May; 15(20):2433-40. PubMed ID: 19468990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical markers, extracellular components in liver fibrosis and cirrhosis.
    Bolarin DM; Azinge EC
    Nig Q J Hosp Med; 2007; 17(1):42-52. PubMed ID: 17688172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario.
    Parola M; Marra F; Pinzani M
    Mol Aspects Med; 2008; 29(1-2):58-66. PubMed ID: 18022682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Fibrosis: Understanding the Dynamics of Bidirectional Wound Repair to Inform the Design of Markers and Therapies.
    Iredale JP; Pellicoro A; Fallowfield JA
    Dig Dis; 2017; 35(4):310-313. PubMed ID: 28467988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatic fibrogenesis].
    Lee KS
    Korean J Gastroenterol; 2006 Nov; 48(5):297-305. PubMed ID: 17132917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Matrix Molecular Remodeling in Human Liver Fibrosis Evolution.
    Baiocchini A; Montaldo C; Conigliaro A; Grimaldi A; Correani V; Mura F; Ciccosanti F; Rotiroti N; Brenna A; Montalbano M; D'Offizi G; Capobianchi MR; Alessandro R; Piacentini M; Schininà ME; Maras B; Del Nonno F; Tripodi M; Mancone C
    PLoS One; 2016; 11(3):e0151736. PubMed ID: 26998606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver fibrosis: a dynamic and potentially reversible process.
    Povero D; Busletta C; Novo E; di Bonzo LV; Cannito S; Paternostro C; Parola M
    Histol Histopathol; 2010 Aug; 25(8):1075-91. PubMed ID: 20552556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum laboratory markers for noninvasive diagnosis and monitoring of liver fibrogenesis in patients with chronic liver diseases.
    Vozar I
    Bratisl Lek Listy; 2005; 106(3):123-6. PubMed ID: 16026147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrosis in the liver: acute protection and chronic disease.
    Lee Y; Friedman SL
    Prog Mol Biol Transl Sci; 2010; 97():151-200. PubMed ID: 21074733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatic fibrogenesis].
    Loréal O; Clément B; Deugnier Y
    Rev Prat; 1997 Mar; 47(5):482-6. PubMed ID: 9138408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of novel biomarkers of liver cirrhosis by proteomic analysis.
    Mölleken C; Sitek B; Henkel C; Poschmann G; Sipos B; Wiese S; Warscheid B; Broelsch C; Reiser M; Friedman SL; Tornøe I; Schlosser A; Klöppel G; Schmiegel W; Meyer HE; Holmskov U; Stühler K
    Hepatology; 2009 Apr; 49(4):1257-66. PubMed ID: 19177598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition.
    Svegliati-Baroni G; De Minicis S; Marzioni M
    Liver Int; 2008 Sep; 28(8):1052-64. PubMed ID: 18783548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of epithelial-mesenchymal transition in liver fibrosis.
    Yu K; Li Q; Shi G; Li N
    Saudi J Gastroenterol; 2018; 24(1):5-11. PubMed ID: 29451178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular MRI quantification of extracellular aldehyde pairs for early detection of liver fibrogenesis and response to treatment.
    Ning Y; Zhou IY; Roberts JD; Rotile NJ; Akam E; Barrett SC; Sojoodi M; Barr MN; Punshon T; Pantazopoulos P; Drescher HK; Jackson BP; Tanabe KK; Caravan P
    Sci Transl Med; 2022 Sep; 14(663):eabq6297. PubMed ID: 36130015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.